Biobot Surgical Pte Ltd was incorporated in 2007 in Singapore, and became a member of ZIG Ventures since 2013. To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application. To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world. Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs.
